Skip to search formSkip to main contentSkip to account menu

dihydrocarminomycin

Known as: 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-1,6,8,11-tetrahydroxy-8-(1-hydroxyethyl)-, carminomycinol 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1982
1982
Carminomycin (CMN) was administered i.v. to 44 patients with a variety of nonhematological cancers every 4 weeks at doses of 15… 
1982
1982
Carminomycin, an antitumor antibiotic, and 13-dihydrocarminomycin, its main metabolite, were determined in the blood plasma of… 
1980
1980
Three components differing by their properties from the carminomycins described earlier were isolated from the carminomycin… 
1978
1978
: The experiments on albino mice treated with rubomycin, carminomycin or dihydrocarminomycin on its 5-fold intravenous… 
1978
1978
The experiments on albino mice treated with rubomycin, carminomycin or dihydrocarminomycin on its 5-fold intravenous… 
1976
1976
A dihydro derivative of karminomycin was prepared using chemical reduction with potassium boron hydride. When dihydrokarminomycin… 
1976
1976
A dihydro derivative of karminomycin was prepared using chemical reduction with potassium boron hydride. When dihydrokarminomycin…